HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Abstract
The aim was to investigate the association between pre-diagnostic intakes of polyphenol classes (flavonoids, lignans, phenolic acids, stilbenes, and other polyphenols) in relation to breast cancer survival (all-cause and breast cancer-specific mortality). We used data from the European Prospective Investigation into Cancer and Nutrition cohort. Pre-diagnostic usual diet was assessed using dietary questionnaires, and polyphenol intakes were estimated using the Phenol-Explorer database. We followed 11,782 breast cancer cases from time of diagnosis until death, end of follow-up or last day of contact. During a median of 6 years, 1482 women died (753 of breast cancer). We related polyphenol intake to all-cause and breast cancer-specific mortality using Cox proportional hazard models with time since diagnosis as underlying time and strata for age and country. Among postmenopausal women, an intake of lignans in the highest versus lowest quartile was related to a 28 % lower risk of dying from breast (adjusted model: HR, quartile 4 vs. quartile 1, 0.72, 95 % CI 0.53; 0.98). In contrast, in premenopausal women, a positive association between lignan intake and all-cause mortality was found (adjusted model: HR, quartile 4 vs. quartile 1, 1.63, 95 % CI 1.03; 2.57). We found no association for other polyphenol classes. Intake of lignans before breast cancer diagnosis may be related to improved survival among postmenopausal women, but may on the contrary worsen the survival for premenopausal women. This suggests that the role of phytoestrogens in breast cancer survival is complex and may be dependent of menopausal status.
AuthorsCecilie Kyrø, Raul Zamora-Ros, Augustin Scalbert, Anne Tjønneland, Laure Dossus, Christoffer Johansen, Pernille Envold Bidstrup, Elisabete Weiderpass, Jane Christensen, Heather Ward, Dagfinn Aune, Elio Riboli, Mathilde His, Françoise Clavel-Chapelon, Laura Baglietto, Verena Katzke, Tilman Kühn, Heiner Boeing, Anna Floegel, Kim Overvad, Cristina Lasheras, Noémie Travier, Maria-José Sánchez, Pilar Amiano, Maria-Dolores Chirlaque, Eva Ardanaz, Kay-Tee Khaw, Nick Wareham, Aurora Perez-Cornago, Antonia Trichopoulou, Pagona Lagiou, Effie Vasilopoulou, Giovanna Masala, Sara Grioni, Franco Berrino, Rosario Tumino, Carlotta Sacerdote, Amalia Mattiello, H Bas Bueno-de-Mesquita, Petra H Peeters, Carla van Gils, Signe Borgquist, Salma Butt, Anne Zeleniuch-Jacquotte, Malin Sund, Anette Hjartåker, Guri Skeie, Anja Olsen, Isabelle Romieu
JournalBreast cancer research and treatment (Breast Cancer Res Treat) Vol. 154 Issue 2 Pg. 389-401 (Nov 2015) ISSN: 1573-7217 [Electronic] Netherlands
PMID26531755 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Polyphenols
Topics
  • Adult
  • Aged
  • Biomarkers, Tumor
  • Breast Neoplasms (diagnosis, epidemiology, etiology, mortality)
  • Diet
  • Dietary Supplements
  • Europe (epidemiology)
  • Female
  • Follow-Up Studies
  • Health Surveys
  • Humans
  • Life Style
  • Middle Aged
  • Mortality
  • Neoplasm Grading
  • Neoplasm Staging
  • Nutrition Surveys
  • Polyphenols (administration & dosage)
  • Proportional Hazards Models
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: